These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 25764671)

  • 1. [Epidemiology of hepatitis C virus infection in Japan].
    Tanaka J; Katayama K
    Nihon Rinsho; 2015 Feb; 73(2):201-7. PubMed ID: 25764671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National prevention of hepatocellular carcinoma in Japan based on epidemiology of hepatitis C virus infection in the general population.
    Yoshizawa H; Tanaka J; Miyakawa Y
    Intervirology; 2006; 49(1-2):7-17. PubMed ID: 16166783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A national project for the management of viral hepatitis toward prevention of hepatocellular carcinoma in Japan].
    Tanaka J; Yoshizawa H
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):864-70. PubMed ID: 15222102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural histories of hepatitis C virus infection in men and women simulated by the Markov model.
    Tanaka J; Kumada H; Ikeda K; Chayama K; Mizui M; Hino K; Katayama K; Kumagai J; Komiya Y; Miyakawa Y; Yoshizawa H
    J Med Virol; 2003 Jul; 70(3):378-86. PubMed ID: 12767000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of medical examination for HCV infection as a national project for prevention of hepatocellular carcinoma in Japan].
    Katayama K; Tanaka J; Komiya Y; Kumagai J; Yoshizawa H
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):248-52. PubMed ID: 15359801
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidemiology of hepatitis C virus in japan.
    Moriya T; Koyama T; Tanaka J; Mishiro S; Yoshizawa H
    Intervirology; 1999; 42(2-3):153-8. PubMed ID: 10516469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total numbers of undiagnosed carriers of hepatitis C and B viruses in Japan estimated by age- and area-specific prevalence on the national scale.
    Tanaka J; Koyama T; Mizui M; Uchida S; Katayama K; Matsuo J; Akita T; Nakashima A; Miyakawa Y; Yoshizawa H
    Intervirology; 2011; 54(4):185-95. PubMed ID: 21454956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Estimation of HBV and/or HCV carrier populations in Hiroshima prefecture and in Japan based on the date from voluntary blood donors].
    Tanaka J
    Nihon Koshu Eisei Zasshi; 1997 Oct; 44(10):788-96. PubMed ID: 9436387
    [No Abstract]   [Full Text] [Related]  

  • 9. [Area and age specific prevalence rate of HCV infection in Japan].
    Tanaka J; Kumagai J; Komiya Y; Yoshizawa H
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):253-7. PubMed ID: 15359802
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatitis C virus infection in japan--epidemiology].
    Tanaka J; Katayama K
    Nihon Rinsho; 2011 May; 69 Suppl 4():15-22. PubMed ID: 22096887
    [No Abstract]   [Full Text] [Related]  

  • 11. [Epidemiology of hepatitis C virus and hepatocellular carcinoma in Japan].
    Tanaka T; Hirota Y; Nishiguchi S
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):611-4. PubMed ID: 15359870
    [No Abstract]   [Full Text] [Related]  

  • 12. Transmission of hepatitis C virus by health care workers in a rural area of Japan.
    Hayashi J; Kishihara Y; Yamaji K; Yoshimura E; Kawakami Y; Akazawa K; Kashiwagi S
    Am J Gastroenterol; 1995 May; 90(5):794-9. PubMed ID: 7537445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatitis C].
    Tazuma S; Chayama K
    Nihon Rinsho; 2002 Jan; 60 Suppl 1():213-9. PubMed ID: 11838117
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis.
    Yamanaka T; Shiraki K; Nakazaawa S; Okano H; Ito T; Deguchi M; Takase K; Nakano T
    Anticancer Res; 2001; 21(4B):2937-40. PubMed ID: 11712790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and clinical aspects on hepatitis C.
    Higuchi M; Tanaka E; Kiyosawa K
    Jpn J Infect Dis; 2002 Jun; 55(3):69-77. PubMed ID: 12195046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan.
    Boschi-Pinto C; Stuver S; Okayama A; Trichopoulos D; Orav EJ; Tsubouchi H; Mueller N
    J Infect Dis; 2000 Jan; 181(1):35-41. PubMed ID: 10608748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy.
    Takai S; Tsurumi H; Ando K; Kasahara S; Sawada M; Yamada T; Hara T; Fukuno K; Takahashi T; Oyama M; Onishi H; Tomita E; Takami T; Imawari M; Moriwaki H
    Eur J Haematol; 2005 Feb; 74(2):158-65. PubMed ID: 15654908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiological and clinical significance of HCV antibody--future problems].
    Nishioka K
    Nihon Rinsho; 1991 Feb; 49(2):267-72. PubMed ID: 1849181
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial management.
    De Vroey B; Moreno C; Laleman W; van Gossum M; Colle I; de Galocsy C; Langlet P; Robaeys G; Orlent H; Michielsen P; Delwaide J; Reynaert H; D'Heygere F; Sprengers D; Bourgeois S; Assene C; Vos B; Brenard R; Adler M; Henrion J; Deltenre P
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):613-9. PubMed ID: 23325285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical investigation of HCV antibodies positive cases in the district with high mortality rate of liver diseases in Saga Prefecture].
    Hara T; Setoguchi Y; Yamamoto K; Ozaki I; Wada I; Fukusima N; Mizuta T; Kajihara S; Sakai T
    Fukuoka Igaku Zasshi; 1993 Feb; 84(2):54-7. PubMed ID: 8390393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.